{"id":"https://openalex.org/W4392354065","doi":"https://doi.org/10.1158/1557-3265.endo24-a008","title":"Abstract A008: Intermittent fasting in combination with PD-inhibitor treatment as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer","display_name":"Abstract A008: Intermittent fasting in combination with PD-inhibitor treatment as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer","publication_year":2024,"publication_date":"2024-03-01","ids":{"openalex":"https://openalex.org/W4392354065","doi":"https://doi.org/10.1158/1557-3265.endo24-a008"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.endo24-a008","doi":"https://doi.org/10.1158/1557-3265.endo24-a008","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3265.endo24-a008","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108276029","display_name":"Jennifer G. Haag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Haag","raw_affiliation_strings":["1University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102923192","display_name":"Olivia D. Lara","orcid":"https://orcid.org/0000-0002-3540-5804","observed_orcids":["https://orcid.org/0000-0002-3540-5804"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olivia Lara","raw_affiliation_strings":["1University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084844090","display_name":"Chunxiao Zhou","orcid":"https://orcid.org/0000-0002-1257-9537","observed_orcids":["https://orcid.org/0000-0002-1257-9537"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chunxiao Zhou","raw_affiliation_strings":["1University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036400845","display_name":"Stephen David Hursting","orcid":"https://orcid.org/0000-0003-3605-2833","observed_orcids":["https://orcid.org/0000-0003-3605-2833"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen D. Hursting","raw_affiliation_strings":["1University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007925500","display_name":"Victoria Lin Bae-Jump","orcid":"https://orcid.org/0000-0001-6778-0951","observed_orcids":["https://orcid.org/0000-0001-6778-0951"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria Bae-Jump","raw_affiliation_strings":["1University of North Carolina, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Carolina, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"5_Supplement","first_page":"A008","last_page":"A008"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12745","display_name":"Dietary Effects on Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12745","display_name":"Dietary Effects on Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9779999852180481},{"id":"https://openalex.org/keywords/intermittent-energy-restriction","display_name":"intermittent energy restriction","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.746999979019165},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6700000166893005},{"id":"https://openalex.org/keywords/high-fat-diet","display_name":"high-fat diet","score":0.593999981880188},{"id":"https://openalex.org/keywords/low-fat-diet","display_name":"low-fat diet","score":0.9549999833106995},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6970000267028809},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9269999861717224},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/liver-kinase-b1","display_name":"LKB1","score":0.5019999742507935},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9020000100135803},{"id":"https://openalex.org/keywords/endometrioid-carcinoma","display_name":"endometrioid carcinoma","score":0.6600000262260437},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6449999809265137},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.6600000262260437},{"id":"https://openalex.org/keywords/tnf-signaling","display_name":"TNF signaling","score":0.8420000076293945},{"id":"https://openalex.org/keywords/mouse-model","display_name":"mouse model","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.7960688471794128},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6652064323425293},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5560504794120789},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46660277247428894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4585932791233063},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.4452635645866394},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43284517526626587}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.endo24-a008","doi":"https://doi.org/10.1158/1557-3265.endo24-a008","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3265.endo24-a008","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393071862","https://openalex.org/W4295227041","https://openalex.org/W4386948506","https://openalex.org/W4395475107","https://openalex.org/W2953550438","https://openalex.org/W7155362810","https://openalex.org/W4281732338","https://openalex.org/W3194659007","https://openalex.org/W2470224990","https://openalex.org/W4403251139"],"abstract_inverted_index":{"Abstract":[0],"Objective:":[1],"Endometrial":[2,530],"cancer":[3,76,520],"(EC)":[4],"incidence":[5,383],"and":[6,33,47,61,71,88,243,247,255,288,309,316,336,353,391,424],"mortality":[7],"continue":[8],"to":[9,37,44,57,65,122,166,199,233,283,325,429,457],"rise,":[10],"with":[11,22,69,99,129,192,211,470,505],"obesity":[12],"a":[13,34,115,134,214,267,484,514],"well-known":[14],"driver":[15],"of":[16,27,49,114,137,154,159,186,206,241,253,280,296,330,343,482,517,524],"this":[17,92],"disease.":[18],"Obesity":[19,264],"is":[20,55],"associated":[21],"excess":[23],"estrogen,":[24],"hyperinsulinemia,":[25],"activation":[26],"the":[28,45,111,161,195,294,341,366,387,394,402,452,480,525],"Akt/mTOR":[29],"pathway,":[30],"chronic":[31],"inflammation":[32],"heightened":[35],"capacity":[36],"harvest":[38],"dietary":[39,93],"energy,":[40],"which":[41,102],"all":[42,188,443],"contribute":[43],"development":[46],"progression":[48],"EC.":[50,107,140],"Intermittent":[51,501],"energy":[52],"restriction":[53],"(IER)":[54],"thought":[56],"have":[58,66],"anti-tumorigenic":[59,112],"benefits":[60],"has":[62],"been":[63],"shown":[64],"synergistic":[67],"effects":[68,113],"chemotherapy":[70],"hormonal":[72],"therapy":[73,303],"in":[74,106,133,236,251,266,270,293,313,328,334,347,365,386,393,401,416,451,479,503,513],"various":[75],"types.":[77],"IER":[78,124,469],"may":[79,474],"also":[80],"promote":[81],"anti-tumor":[82],"immune":[83,237],"responses":[84],"by":[85,260],"stimulating":[86],"CD4+":[87,246,308,331],"CD8+":[89,248,310,344],"cells,":[90],"making":[91],"strategy":[94,478,512],"an":[95,326,476,509],"innovative":[96,477,510],"therapeutic":[97],"partner":[98],"PD-1":[100,130,216,301,305,321,355,435,471],"inhibitors,":[101],"are":[103],"commonly":[104],"used":[105],"Thus,":[108],"we":[109],"evaluated":[110,259],"switch":[116,172,376,380,422,426],"from":[117],"high":[118],"fat":[119],"diet":[120,127,404,444],"(HFD)":[121],"either":[123,146],"or":[125,148,173,213,378,465],"low-fat":[126],"(LFD)":[128],"inhibitor":[131,217,302,322,356,436,472],"treatment":[132,168,323,437,473,507,511],"mouse":[135,215],"model":[136,516],"obesity-driven":[138,486,518],"endometrioid":[139],"Methods:":[141],"Lkb1fl/flp53fl/fl":[142],"mice":[143,163,178,189,208,227,257,277,417,432,458],"were":[144,164,179,190,209,258,291,361,399,413],"fed":[145,418],"HFD":[147,367,395,461],"LFD":[149,373,419,466],"starting":[150],"at":[151],"4":[152,224],"weeks":[153,158,185,205],"age.":[155],"At":[156,183,203,351],"12":[157],"age,":[160,187,207],"HFD-fed":[162,431],"randomized":[165],"three":[167],"groups:":[169],"HFD,":[170],"HFD-LFD":[171,375,421,463],"HFD-IER":[174,379,388,425,453],"switch.":[175],"The":[176],"LFD-fed":[177],"maintained":[180],"on":[181,307,529],"LFD.":[182],"16":[184],"injected":[191],"AdCre":[193],"into":[194],"left":[196],"uterine":[197],"horn":[198],"induce":[200],"EC":[201,382,439],"development.":[202],"26":[204],"treated":[210],"placebo":[212],"(BioXCell)":[218],"(10mg/kg,":[219],"2":[220],"times/wk,":[221],"intraperitoneal)":[222],"for":[223],"wks":[225],"(N=8-10":[226],"per":[228],"group).":[229],"RNAseq":[230],"was":[231,384,449],"performed":[232],"determine":[234],"differences":[235],"pathways":[238,290],"between":[239],"ECs":[240,295,338],"obese":[242,254,274,297,315,335],"lean":[244,256,276,299,317,337,349],"mice.":[245,300],"T":[249,311,332,345],"cells":[250,312,333,346],"tumors":[252],"flow":[261],"cytometry.":[262],"Results:":[263],"resulted":[265],"52%":[268],"increase":[269,327],"tumor":[271,411],"size,":[272],"comparing":[273],"versus":[275,298],"(p<0.05).":[278],"Expression":[279],"genes":[281],"related":[282],"T-cell/B-cell":[284],"receptors,":[285],"NF-kappa":[286],"B":[287],"TNF":[289],"upregulated":[292],"increased":[304,340],"expression":[306],"both":[314],"ECs.":[318,350],"In":[319,407],"addition,":[320],"led":[324],"percentage":[329,342],"but":[339],"only":[348],"sacrifice":[352],"after":[354],"treatment,":[357],"mean":[358,410],"body":[359],"weights":[360,412],"significantly":[362,414],"higher":[363],"(p<0.05)":[364],"group":[368,389,396,454],"(42g)":[369],"than":[370],"groups":[371,405,445],"receiving":[372,459],"(29g),":[374],"(34g)":[377],"(23g).":[381],"lowest":[385],"(~61%)":[390],"highest":[392],"(~80%);":[397],"rates":[398],"similar":[400],"other":[403],"(~75%).":[406],"placebo-treated":[408],"groups,":[409],"lower":[415],"(0.45g),":[420],"(0.41g)":[423],"(0.29g)":[427],"relative":[428,456],"continuous":[430,460],"(0.94g;":[433],"p=0.001-0.05).":[434],"reduced":[438],"size":[440,447],"24-68%":[441],"across":[442],"(p=0.05-0.001);":[446],"reduction":[448],"greatest":[450],"(0.18g)":[455],"(0.30g),":[462],"(0.31g)":[464],"(0.31g).":[467],"Conclusion:":[468],"be":[475],"management":[481],"EC,":[483],"highly":[485],"cancer.":[487],"Citation":[488],"Format:":[489],"Jennifer":[490],"Haag,":[491],"Olivia":[492],"Lara,":[493],"Chunxiao":[494],"Zhou,":[495],"Stephen":[496],"D.":[497],"Hursting,":[498],"Victoria":[499],"Bae-Jump.":[500],"fasting":[502],"combination":[504],"PD-inhibitor":[506],"as":[508],"pre-clinical":[515],"endometrial":[519],"[abstract].":[521],"In:":[522],"Proceedings":[523],"AACR":[526],"Special":[527],"Conference":[528],"Cancer:":[531],"Transforming":[532],"Care":[533],"through":[534],"Science;":[535],"2023":[536],"Nov":[537],"16-18;":[538],"Boston,":[539],"Massachusetts.":[540],"Philadelphia":[541],"(PA):":[542],"AACR;":[543],"Clin":[544],"Cancer":[545],"Res":[546],"2024;30(5_Suppl):Abstract":[547],"nr":[548],"A008.":[549]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-05T00:00:00"}